ChemBridge Corporation is a privately held provider of chemistry tools for small molecule drug discovery.
Over 700 R&D companies and research institutes worldwide have taken advantage of our stock comprising more than 1,000,000 small molecules and 15,000 building blocks. Our R&D and production divisions are aimed at diverse and targeted small molecule collections for drug discovery, proprietary building blocks synthesis, advanced lead generation and lead development.
